CSTL icon

Castle Biosciences
CSTL

Overview Fund Activity

162 hedge funds and large institutions have $1.29B invested in Castle Biosciences in 2020 Q4 according to their latest regulatory filings, with 38 funds opening new positions, 64 increasing their positions, 45 reducing their positions, and 19 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
162
Holders Change
+18
Holders Change %
+12.5%
% of All Funds
2.87%
Holding in Top 10
4
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.07%
New
38
Increased
64
Reduced
45
Closed
19
Calls
$8.19M
Puts
$3.16M
Net Calls
+$5.03M
Net Calls Change
+$5.82M

Top Buyers

1
AIM
1
ARK Investment Management
Florida
$139M
2
Invesco
2
Invesco
Georgia
$75.1M
3
MCMC
3
Matrix Capital Management Company
New Hampshire
$67.2M
4
WA
4
Wasatch Advisors
Utah
$139M
5
GKIM
5
GW&K Investment Management
Massachusetts
$30.4M

Top Sellers

1
NAM
1
Nexpoint Asset Management
Texas
$0
2
UOTTAIMCU
2
University of Texas/Texas AM Investment Management Co (UTIMCO)
Texas
$0
3
GIM
3
Granahan Investment Management
Massachusetts
$15.2M
4
Bank of Montreal
4
Bank of Montreal
Ontario, Canada
$5.13M
5
OFG
5
Oxford Financial Group
Indiana
$362K
Name Holding Trade Value Shares
Change 		Shares
Change %
Renaissance Technologies
176
Renaissance Technologies
New York
– -$201K -3,900 Closed
MAM
177
Meeder Asset Management
Ohio
– -$66K -1,294 Closed
CCM
178
Chiron Capital Management
Florida
– -$18K -350 Closed
VI
179
Vestcor Inc
New Brunswick, Canada
– -$16K -318 Closed
QT
180
Quantbot Technologies
New York
– -$10K -200 Closed
Simplex Trading
181
Simplex Trading
Illinois
– -$7K -138 Closed
4 5 6 7
8